UPC faces first bifurcation challenge in Amgen v Sanofi/Regeneron spat
Amgen is contesting the admissibility of a revocation action filed against it, claiming its infringement suit was filed first
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.